Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + Decitabine/Azacitidine + Aclarubicin in Treatment-Naive Elderly AML
NCT05264883Phase 3Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Mar 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aclarubicin in acute myeloid leukemia (AML), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
aclarubicin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05264883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05264883.